Hematology
1428 articles · 38 journals
Journals in this subcategory (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (89)
- Blood Advances · Elsevier (89)
- Journal of Thrombosis and Haemostasis · Elsevier (86)
- Thrombosis Research · Elsevier (81)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (80)
- British Journal of Haematology · Wiley (78)
- European Journal of Haematology · Wiley (74)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (73)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (68)
- Blood · Elsevier (65)
- Vox Sanguinis · Wiley (65)
- Annals of Oncology · Elsevier (64)
- American Journal of Hematology · Wiley (58)
- Haemophilia · Wiley (58)
- Transfusion · Wiley (53)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- The Lancet Haematology · Elsevier (28)
- Seminars in Oncology · Elsevier (27)
- Experimental Hematology · Elsevier (21)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (14)
- Transfusion Medicine · Wiley (13)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (8)
- Leukemia · Springer Nature (8)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
-
Impact of race/ethnicity, donor and recipient age, and donor on survival after allogeneic transplant in the post-transplant cyclophosphamide era
Blood Cancer Journal, Published online: 17 November 2026; doi:10.1038/s41408-026-01670-0 Impact of race/ethnicity, donor and recipient age, and donor on survival after allogeneic transplant in the post-transplant cyclophosphamide era
-
European LeukemiaNet clinical signs and symptoms as prognostic markers in polycythemia vera during ruxolitinib
Leukemia, Published online: 17 November 2026; doi:10.1038/s41375-026-03183-y European LeukemiaNet clinical signs and symptoms as prognostic markers in polycythemia vera during ruxolitinib
-
Validity and Reliability of a Thai Version of the Paediatric Haemophilia Activities List
ABSTRACT Introduction The Paediatric Haemophilia Activities List (PedHAL) is a self‐administered instrument for assessing activity limitations in children with haemophilia, yet no Thai version has previously undergone psychometric...
-
A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study
Summary Patient‐reported outcome (PRO) and quality of life (QoL) assessments for multiple myeloma (MM) patients are traditionally collected at infrequent intervals using burdensome instruments, resulting in limited clinical visibility...
-
Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia
ABSTRACT Introduction Von Willebrand factor (VWF) and factor VIII (FVIII) levels are influenced by multiple physiological and disease‐related factors. Patients with transfusion‐dependent beta thalassemia (TDT) present a complex clinical...
-
Efficacy, Safety, and Durability of Sutimlimab in Cold Agglutinin Disease: A Systematic Review and Meta‐Analysis
ABSTRACT Introduction Sutimlimab, a C1s inhibitor, is the only agent approved for hemolysis in cold agglutinin disease (CAD). Its evidence base has expanded through extensions, access programs, and registries that may re‐report...
-
Chronic Lymphocytic Leukaemia as a Disease of Time: A Four‐Clock Framework for Therapeutic Stewardship
ABSTRACT Chronic lymphocytic leukaemia (CLL) is defined not only by disease biology but also by time. Its natural history reflects the pace of clonal evolution, the changing reserve of host immunity, the ordered use of therapeutic...
-
CD20 antigen loss post‐venetoclax/anti‐CD20 therapy in chronic lymphocytic leukaemia: Frequency, characteristics and potential therapeutic implications
Summary Venetoclax plus anti‐CD20 monoclonal antibody (mAb) regimens have revolutionised treatment for chronic lymphocytic leukaemia (CLL); however, CD20 antigen loss is a potential consequence. Given emerging roles for re‐treatment...
-
Comparative Prognostic Value of Mayo 2012 and European‐Modified Mayo 2004 Staging Systems in Systemic AL Amyloidosis With Discordant Risk Classification
ABSTRACT Objectives The Mayo 2012 and European‐modified Mayo 2004 (European‐modified) staging systems are widely used in systemic light‐chain (AL) amyloidosis, but their comparative prognostic performance in patients with discordant...
- Correction to ‘Risk factors and reasons for switching from front‐line therapy in the Italian chronic myeloid leukaemia network: A cohort study’
-
Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to zoledronic acid (ZA) after definitive radiation (alliance A061402)
Blood Cancer Journal, Published online: 16 November 2026; doi:10.1038/s41408-026-01674-w Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to...
-
Impact of the Lebanese Crisis on the Treatment of Patients With Haemophilia and von Willebrand Disease
ABSTRACT Introduction Haemophilia and von Willebrand disease (VWD) are inherited bleeding disorders requiring lifelong access to haemostatic therapies and coordinated multidisciplinary care. Lebanon's prolonged economic and healthcare...
-
Development of Haemophilia Specialist Nurses and Current Status Survey of Nursing Practice in China
ABSTRACT Introduction Little is known about the breadth of nursing practice and its determinants among haemophilia specialist nurses in China. Aim To review the evolution of haemophilia specialist nursing in China and investigate the...
-
HLA‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply
Abstract Background Low titer group O whole blood (LTOWB) use across the United States is increasing. This simulation calculated the number of female donors who would qualify for LTOWB donation if HLA‐antibody screening was implemented...
-
The viability and oxidative‐biochemical status of platelets in platelet concentrate prepared from male and female blood donors during storage in plasma
Abstract Background and Objective Platelet storage lesion (PSL) adversely impacts the quality of platelet concentrates (PCs). During PSL, platelets lose 40%–50% of their metabolic activity due to temperature changes and shifting from...
- Is There an Association Between GLP‐1RA Use and Blood Cancer Incidence or Progression?
-
Optimizing Frontline Targeted Therapies in Chronic Lymphocytic Leukemia: An Italian Inter‐Regional Delphi Consensus on Patient Risk Stratification, Cardiovascular Safety, and Endpoint Interpretation
ABSTRACT Background While landmark trial data have established targeted agents as the frontline standard of care in chronic lymphocytic leukemia (CLL), real‐world clinical gaps remain regarding high‐risk disease biology, patient...
-
Ravulizumab Shows Favorable Survival and Improves Clinical Markers in Children With HSCT‐TMA: Results of a Phase 3 Trial
ABSTRACT Hematopoietic stem cell transplantation‐associated thrombotic microangiopathy (HSCT‐TMA) is a rare, life‐threatening complication that can lead to multiorgan failure and death. The ALXN1210‐TMA‐314 global, Phase 3, open‐label,...
- Convalescent blood in Ebola: From a survivor's gift to a biologically defined therapeutic product
-
Implications of TP53 mutations in patients with higher risk myelodysplastic syndromes (MDS) who received hypomethylating agent therapy: an analysis from the VALIDATE database of the International Consortium for MDS
Blood Cancer Journal, Published online: 14 November 2026; doi:10.1038/s41408-026-01584-x Implications of TP53 mutations in patients with higher risk myelodysplastic syndromes (MDS) who received hypomethylating agent therapy: an analysis...
-
Evaluation of rare and novel splicing variants in the RH system
Abstract Background Single nucleotide variants near intron/exon junctions can affect RNA splicing, resulting in weak or loss of blood group antigen expression. We investigated 11 samples with no causative variants found in RH coding...
-
Caregiver support in patients with plasma cell dyscrasias: A novel single‐item pilot measure of caregiver availability: Results from a survey of >1000 patients
Summary Treatment for plasma cell dyscrasias imposes burdens on patients and caregivers, particularly for cellular therapies. Traditional social determinants of health may not capture caregiver availability. We conducted a...
-
Impact of residual clonal plasma cell proliferation rate after autologous stem cell transplant on outcomes in multiple myeloma
Blood Cancer Journal, Published online: 13 November 2026; doi:10.1038/s41408-026-01676-8 Impact of residual clonal plasma cell proliferation rate after autologous stem cell transplant on outcomes in multiple myeloma
- Screening for prostate cancer
- American Cancer Society guideline for the early detection of prostate cancer, 2026
- Issue Information
- British Society for Haematology guideline on transfusion for fetuses, neonates and older children
- Response to: Comment on ‘Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6‐related thrombocytopenia’
- Comment on ‘Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6‐related thrombocytopenia’
-
Recipient and donor contact following unrelated allogeneic hematopoietic cell transplantation: The Canadian Blood Services' stem cell registry experience
Abstract Background Communication between recipients and their unrelated donors following hematopoietic cell transplantation (HCT) presents an important aspect of human connection that remains underreported. Characterizing...